ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LIFE aTyr Pharma Inc

1.70
0.04 (2.41%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
aTyr Pharma Inc NASDAQ:LIFE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.04 2.41% 1.70 1.67 1.72 1.7099 1.64 1.69 256,475 00:32:34

Amended Statement of Beneficial Ownership (3/a)

12/05/2017 12:17am

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Blackburn Stan

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/11/2017 

3. Issuer Name and Ticker or Trading Symbol

aTYR PHARMA INC [LIFE]

(Last)        (First)        (Middle)

3545 JOHN HOPKINS COURT, SUITE 250

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
_____ Officer (give title below)          ___ X ___ Other (specify below)
/ Prior Acting CFO

(Street)

SAN DIEGO, CA 92121       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

5/6/2015 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   11805   (1) I   By the J. Stanhope and Karlene S. Blackburn Family Trust U.T.D. May 9, 2001   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The 93,901 shares previously reported on May 6, 2015 were not adjusted for a one-for-7.95413 reverse stock split of our common stock on May 5, 2015 in connection with our initial public offering. The pre-split number of shares was inadvertently reported rather than the post-split number of shares.
(2)  The Reporting Person is a co-trustee of the J. Stanhope Blackburn and Karlene S. Blackburn Family Trust U.T.D. May 9, 2001.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Blackburn Stan
3545 JOHN HOPKINS COURT, SUITE 250
SAN DIEGO, CA 92121



Prior Acting CFO

Signatures
Nancy D. Krueger, Attorney-In-Fact 5/11/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year aTyr Pharma Chart

1 Year aTyr Pharma Chart

1 Month aTyr Pharma Chart

1 Month aTyr Pharma Chart

Your Recent History

Delayed Upgrade Clock